arterial tortuosity syndrome |
Disease ID | 734 |
---|---|
Disease | arterial tortuosity syndrome |
Definition | Arterial tortuosity syndrome (ATS) is a rare congenital connective tissue condition disorder characterized by elongation and generalized tortuosity of the major arteries including the aorta. It is associated with hyperextensible skin and hypermobility of joints, however symptoms vary depending on the patient. Because ATS is so rare, not much is known about the disease. - Wikipedia Reference: https://en.wikipedia.org/wiki/arterial tortuosity syndrome |
Synonym | arterial tortuosity arterial tortuosity syndrome (disorder) |
Orphanet | |
OMIM | |
DOID | |
UMLS | C1859726 |
SNOMED-CT | |
Comorbidity | UMLS | Disease | Sentences' Count(Total Sentences:5) C0003486 | aortic aneurysm | 3 C0007766 | intracranial aneurysm | 1 C0007766 | intracranial aneurysms | 1 C0020538 | hypertension | 1 C0007766 | cranial aneurysm | 1 |
Curated Gene | Entrez_id | Symbol | Resource(Total Genes:1) |
Inferring Gene | (Waiting for update.) |
Text Mined Gene | Entrez_id | Symbol | Score | Resource(Total Genes:16) 1280 | COL2A1 | 1.917 | DISEASES 1289 | COL5A1 | 2.919 | DISEASES 1290 | COL5A2 | 3.17 | DISEASES 1291 | COL6A1 | 2.743 | DISEASES 1490 | CTGF | 1.256 | DISEASES 10516 | FBLN5 | 2.682 | DISEASES 2335 | FN1 | 1.88 | DISEASES 3745 | KCNB1 | 1.312 | DISEASES 4629 | MYH11 | 2.071 | DISEASES 4638 | MYLK | 2.387 | DISEASES 5747 | PTK2 | 1.618 | DISEASES 81031 | SLC2A10 | 7.789 | DISEASES 4088 | SMAD3 | 1.448 | DISEASES 7046 | TGFBR1 | 3.32 | DISEASES 7048 | TGFBR2 | 1.803 | DISEASES 7148 | TNXB | 2.935 | DISEASES |
Locus | Symbol | Locus(Total Locus:1) SLC2A10 | 20q13.12 |
Disease ID | 734 |
---|---|
Disease | arterial tortuosity syndrome |
Integrated Phenotype | HPO | Name(Total Integrated Phenotypes:61) HP:0001263 | Global developmental delay HP:0002094 | Dyspnea HP:0004942 | Aortic aneurysm HP:0012378 | Fatigue HP:0000581 | Blepharophimosis HP:0003196 | Short nose HP:0000545 | Myopia HP:0100585 | Telangiectasia of the skin HP:0001166 | Arachnodactyly HP:0012745 | Short palpebral fissure HP:0001644 | Dilated cardiomyopathy HP:0001838 | Rocker bottom foot HP:0007495 | Prematurely aged appearance HP:0000974 | Hyperextensible skin HP:0002098 | Respiratory distress HP:0100545 | Arterial stenosis HP:0000563 | Keratoconus HP:0001635 | Congestive heart failure HP:0000963 | Thin skin HP:0001637 | Abnormality of the myocardium HP:0005743 | Avascular necrosis of the capital femoral epiphysis HP:0000276 | Long face HP:0000486 | Strabismus HP:0005692 | Joint hyperflexibility HP:0000316 | Hypertelorism HP:0000822 | Hypertension HP:0001639 | Hypertrophic cardiomyopathy HP:0002617 | Aneurysm HP:0002647 | Aortic dissection HP:0002020 | Gastroesophageal reflux HP:0010668 | Abnormality of the zygomatic bone HP:0000256 | Macrocephaly HP:0001658 | Myocardial infarction HP:0004415 | Pulmonary artery stenosis HP:0002650 | Scoliosis HP:0011302 | Long palm HP:0000272 | Malar flattening HP:0001119 | Keratoglobus HP:0004209 | Clinodactyly of the 5th finger HP:0002021 | Pyloric stenosis HP:0012819 | Myocarditis HP:0000023 | Inguinal hernia HP:0100633 | Esophagitis HP:0001249 | Intellectual disability HP:0002616 | Aortic root dilatation HP:0001385 | Hip dysplasia HP:0001363 | Craniosynostosis HP:0002812 | Coxa vara HP:0005344 | Abnormality of the carotid arteries HP:0001582 | Redundant skin HP:0008501 | Median cleft lip and palate HP:0002878 | Respiratory failure HP:0100541 | Femoral hernia HP:0001695 | Cardiac arrest HP:0000400 | Macrotia HP:0001328 | Specific learning disability HP:0002827 | Hip dislocation HP:0006543 | Cardiorespiratory arrest HP:0001252 | Muscular hypotonia HP:0002036 | Hiatus hernia HP:0002673 | Coxa valga |
Text Mined Phenotype | HPO | Name | Sentences' Count(Total Phenotypes:5) |
Disease ID | 734 |
---|---|
Disease | arterial tortuosity syndrome |
Manually Symptom | (Waiting for update.) |
Text Mined Symptom | (Waiting for update.) |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
Text Mining Genotype(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
All Snps(Total Genotypes:20) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
rs121908172 | NA | 81031 | SLC2A10 | umls:C1859726 | CLINVAR | NA | 0.481628651 | NA | SLC2A10 | 20 | 46726312 | G | T |
rs121908173 | NA | 81031 | SLC2A10 | umls:C1859726 | CLINVAR | NA | 0.481628651 | NA | SLC2A10 | 20 | 46725430 | C | T |
rs146579504 | NA | 81031 | SLC2A10 | umls:C1859726 | CLINVAR | NA | 0.481628651 | NA | SLC2A10 | 20 | 46725727 | C | T |
rs370547023 | NA | 81031 | SLC2A10 | umls:C1859726 | CLINVAR | NA | 0.481628651 | NA | SLC2A10 | 20 | 46726905 | C | T |
rs564317065 | 17935213 | 81031 | SLC2A10 | umls:C1859726 | UNIPROT | As such, overt diabetes is not related to SLC2A10 mutations associated with ATS. | 0.481628651 | 2008 | SLC2A10 | 20 | 46725773 | G | A |
rs564317065 | NA | 81031 | SLC2A10 | umls:C1859726 | CLINVAR | NA | 0.481628651 | NA | SLC2A10 | 20 | 46725773 | G | A |
rs572620317 | NA | 81031 | SLC2A10 | umls:C1859726 | CLINVAR | NA | 0.481628651 | NA | SLC2A10 | 20 | 46725453 | T | A,C |
rs587776599 | NA | 81031 | SLC2A10 | umls:C1859726 | CLINVAR | NA | 0.481628651 | NA | SLC2A10 | 20 | 46725997 | G | - |
rs587776600 | NA | 81031 | SLC2A10 | umls:C1859726 | CLINVAR | NA | 0.481628651 | NA | SLC2A10 | 20 | 46726909 | G | - |
rs753723351 | NA | 81031 | SLC2A10 | umls:C1859726 | CLINVAR | NA | 0.481628651 | NA | SLC2A10 | 20 | 46726909 | G | A |
rs756457861 | NA | 81031 | SLC2A10 | umls:C1859726 | CLINVAR | NA | 0.481628651 | NA | SLC2A10 | 20 | 46725721 | C | A,T |
rs763220502 | NA | 81031 | SLC2A10 | umls:C1859726 | CLINVAR | NA | 0.481628651 | NA | SLC2A10 | 20 | 46726884 | G | A |
rs767864243 | NA | 81031 | SLC2A10 | umls:C1859726 | CLINVAR | NA | 0.481628651 | NA | SLC2A10 | 20 | 46725349 | C | T |
rs771028960 | NA | 81031 | SLC2A10 | umls:C1859726 | CLINVAR | NA | 0.481628651 | NA | SLC2A10 | 20 | 46725728 | G | A |
rs80358229 | NA | 81031 | SLC2A10 | umls:C1859726 | CLINVAR | NA | 0.481628651 | NA | SLC2A10 | 20 | 46725546 | G | A |
rs80358230 | NA | 81031 | SLC2A10 | umls:C1859726 | CLINVAR | NA | 0.481628651 | NA | SLC2A10 | 20 | 46725279 | C | G |
rs864309478 | NA | 81031 | SLC2A10 | umls:C1859726 | CLINVAR | NA | 0.481628651 | NA | SLC2A10 | 20 | 46725792 | C | A |
rs864309479 | NA | 81031 | SLC2A10 | umls:C1859726 | CLINVAR | NA | 0.481628651 | NA | SLC2A10 | 20 | 46726987 | G | A |
rs864309480 | NA | 81031 | SLC2A10 | umls:C1859726 | CLINVAR | NA | 0.481628651 | NA | SLC2A10 | 20 | 46725461 | G | T |
rs864309481 | NA | 81031 | SLC2A10 | umls:C1859726 | CLINVAR | NA | 0.481628651 | NA | SLC2A10 | 20 | 46725766 | CTAA | - |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:24) | ||||
---|---|---|---|---|
HP ID | HP Name | MP ID | MP Name | Annotation |
HP:0002021 | Pyloric stenosis | MP:0006128 | pulmonary valve stenosis | abnormal narrowing of the pulmonary valve |
HP:0003196 | Short nose | MP:0002233 | abnormal nose morphology | any structural anomaly of the organ that is specialized for smell and is part of the respiratory system |
HP:0002647 | Aortic dissection | MP:0004044 | aortic dissection | a pathologic process, characterized by splitting of the media layer of the aorta, which leads to formation of a dissecting aneurysm |
HP:0001644 | Dilated cardiomyopathy | MP:0005330 | cardiomyopathy | diseases of the heart (myocardium); may result from many causes |
HP:0000974 | Hyperextensible skin | MP:0010678 | abnormal skin adnexa morphology | any structural anomaly of the tissue or structures associated with or embedded in the skin such as hair and hair follicles, sweat glands, sebaceous glands and claws or nails |
HP:0001639 | Hypertrophic cardiomyopathy | MP:0005330 | cardiomyopathy | diseases of the heart (myocardium); may result from many causes |
HP:0000023 | Inguinal hernia | MP:0010146 | umbilical hernia | an outward bulging (protrusion) of the abdominal lining or part of the abdominal organ(s) through the area around the umbilicus; occurs when the muscle through which blood vessels pass to feed the developing fetus fails to completely close |
HP:0004209 | Clinodactyly of the 5th finger | MP:0011665 | d-loop transposition of the great arteries | complete transposition of the great arteries; the d- refers to the dextroposition of the bulboventricular loop (ie, the position of the right ventricle, which is on the right side); in addition, the aorta also tends to be on the right and anterior, and th |
HP:0001263 | Global developmental delay | MP:0002084 | abnormal developmental patterning | abnormal systematic arrangement of the developing body along an axis |
HP:0001252 | Muscular hypotonia | MP:0004144 | hypotonia | decreased muscle tension resulting in limpness of the muscles in the resting state, not to be confused with weakness |
HP:0008501 | Median cleft lip and palate | MP:0009890 | cleft secondary palate | congenital fissure of the tissues normally uniting to form the secondary palate |
HP:0001582 | Redundant skin | MP:0010678 | abnormal skin adnexa morphology | any structural anomaly of the tissue or structures associated with or embedded in the skin such as hair and hair follicles, sweat glands, sebaceous glands and claws or nails |
HP:0000963 | Thin skin | MP:0010678 | abnormal skin adnexa morphology | any structural anomaly of the tissue or structures associated with or embedded in the skin such as hair and hair follicles, sweat glands, sebaceous glands and claws or nails |
HP:0001328 | Specific learning disability | MP:0002802 | abnormal discrimination learning | anomaly in the ability to exhibit a differential response to different stimuli that is achieved by the reinforcement of the desired response for each particular stimulus |
HP:0005743 | Avascular necrosis of the capital femoral epiphysis | MP:0008752 | abnormal tumor necrosis factor level | deviation from the normal levels of a serum glycoprotein produced by activated macrophages and NK cells and involved in initiating local inflammatory responses, particularly by its action on the endothelium of local blood vessels; its actions result in in |
HP:0001838 | Rocker bottom foot | MP:0008059 | abnormal podocyte foot process morphology | any structural anomaly of the footlike extension of podocytes that interdigitate with one another to form the walls of the glomerular capillaries |
HP:0001635 | Congestive heart failure | MP:0011925 | abnormal heart echocardiography feature | any anomaly in echocardiographic representation of systolic and diastolic function, ventricular compliance, valvular function, or interventricular septum features |
HP:0000276 | Long face | MP:0012546 | triangular face | a face whose lower half becomes relatively thin, approaching an appearance of a triangle with a tip facing downwards; usually associated with a prominent forehead and micrognathia |
HP:0100545 | Arterial stenosis | MP:0010641 | descending aorta stenosis | diffuse constriction or narrowing of the descending aorta |
HP:0004942 | Aortic aneurysm | MP:0010661 | ascending aorta aneurysm | a protruding sac formed by the dilation of the wall of the of the part of the aorta that arises from the base of the left ventricle and extends upward to the aortic arch, resulting from a weakening of the vessel wall |
HP:0002098 | Respiratory distress | MP:0001954 | respiratory distress | physical difficulty or inability to breathe; shortness of breath |
HP:0004415 | Pulmonary artery stenosis | MP:0012730 | abnormal internal carotid artery morphology | any structural anomaly of the terminal branch of the left or right common carotid artery which supplies oxygenated blood to the brain and eyes |
HP:0002878 | Respiratory failure | MP:0012129 | failure of blastocyst formation | inability to form a blastocyst from a solid ball of cells known as a morula |
HP:0100585 | Telangiectasia of the skin | MP:0011022 | abnormal circadian regulation of systemic arterial blood pressure | any anomaly in the process in which an organism modulates its blood pressure at different values with a regularity of approximately 24 hours |
Mapped by homologous gene(Total Items:58) | ||||
---|---|---|---|---|
HP ID | HP Name | MP ID | MP Name | Annotation |
HP:0001252 | Muscular hypotonia | MP:3000003 | abnormal Ebner's gland morphology | any structural anomaly of the serous salivary glands which reside adjacent to the moats surrounding the circumvallate and foliate papillae just anterior to the posterior third of the tongue, anterior to the terminal sulcus; these exocrine glands secrete l |
HP:0002650 | Scoliosis | MP:0020309 | increased creatine kinase activity | increased ability of to catalyze the reaction: ATP + creatine = N-phosphocreatine + ADP + 2 H(+). |
HP:0002878 | Respiratory failure | MP:0020309 | increased creatine kinase activity | increased ability of to catalyze the reaction: ATP + creatine = N-phosphocreatine + ADP + 2 H(+). |
HP:0001385 | Hip dysplasia | MP:0013293 | embryonic lethality prior to tooth bud stage | death prior to the appearance of tooth buds (Mus: E12-E12.5) |
HP:0002098 | Respiratory distress | MP:0014198 | absent pituitary infundibular stalk | absence of the apical portion of the tubular structure extending from the hypothalamus to the posterior lobe of the pituitary gland |
HP:0002021 | Pyloric stenosis | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0000486 | Strabismus | MP:3000003 | abnormal Ebner's gland morphology | any structural anomaly of the serous salivary glands which reside adjacent to the moats surrounding the circumvallate and foliate papillae just anterior to the posterior third of the tongue, anterior to the terminal sulcus; these exocrine glands secrete l |
HP:0002616 | Aortic root dilatation | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0000276 | Long face | MP:0020309 | increased creatine kinase activity | increased ability of to catalyze the reaction: ATP + creatine = N-phosphocreatine + ADP + 2 H(+). |
HP:0100545 | Arterial stenosis | MP:0020321 | increased vascular endothelial cell apoptosis | increase in the timing or the number of vascular endothelial cells undergoing programmed cell death |
HP:0003196 | Short nose | MP:0020309 | increased creatine kinase activity | increased ability of to catalyze the reaction: ATP + creatine = N-phosphocreatine + ADP + 2 H(+). |
HP:0100541 | Femoral hernia | MP:0013174 | pharynx stenosis | abnormal narrowing or constriction of the passage between the mouth and the posterior nares and the larynx and esophagus |
HP:0002673 | Coxa valga | MP:0020137 | decreased bone mineralization | decrease in the rate at which minerals are deposited into bone |
HP:0002036 | Hiatus hernia | MP:0014178 | increased brain apoptosis | increase in the number of cells of the brain undergoing programmed cell death |
HP:0000316 | Hypertelorism | MP:0020321 | increased vascular endothelial cell apoptosis | increase in the timing or the number of vascular endothelial cells undergoing programmed cell death |
HP:0002094 | Dyspnea | MP:0014185 | cerebellum atrophy | acquired diminution of the size of the cerebellum associated with wasting as from death and reabsorption of cells, diminished cellular proliferation, decreased cellular volume, pressure, ischemia, malnutrition, reduced function or malfunction, or hormonal |
HP:0001363 | Craniosynostosis | MP:0020137 | decreased bone mineralization | decrease in the rate at which minerals are deposited into bone |
HP:0000581 | Blepharophimosis | MP:0020137 | decreased bone mineralization | decrease in the rate at which minerals are deposited into bone |
HP:0002827 | Hip dislocation | MP:0020137 | decreased bone mineralization | decrease in the rate at which minerals are deposited into bone |
HP:0005743 | Avascular necrosis of the capital femoral epiphysis | MP:0014164 | abnormal ciliary process morphology | any structural anomaly of any of the pigmented processes that radiate from the ciliary muscle and give attachments to ligaments supporting the lens of the eye; these processes increase in thickness as they advance from the orbiculus ciliaris to the exter |
HP:0008501 | Median cleft lip and palate | MP:0013906 | absent embryonic telencephalon | absence of the paired diverticula of the embryonic telencephalon, from which the forebrain develops |
HP:0001695 | Cardiac arrest | MP:0013578 | abnormal stomach glandular region morphology | any structural anomaly of the distinct glandular stomach area which in rodents is demarcated from the non-glandular forestomach by the limiting ridge (margo plicatus); the glandular stomach is connected to the small intestine (duodenum); the wall of the g |
HP:0001639 | Hypertrophic cardiomyopathy | MP:0020329 | decreased capillary density | reduction in the number of capillaries in a given cross-sectional area of a tissue |
HP:0012378 | Fatigue | MP:0013659 | abnormal erythroid lineage cell morphology | any structural anomaly of an immature or mature cell in the lineage leading to and including erythrocytes |
HP:0004415 | Pulmonary artery stenosis | MP:0013241 | embryo tissue necrosis | morphological changes resulting from pathological death of some or all embryo tissue; usually due to irreversible damage |
HP:0001644 | Dilated cardiomyopathy | MP:0020329 | decreased capillary density | reduction in the number of capillaries in a given cross-sectional area of a tissue |
HP:0002617 | Aneurysm | MP:0020321 | increased vascular endothelial cell apoptosis | increase in the timing or the number of vascular endothelial cells undergoing programmed cell death |
HP:0001328 | Specific learning disability | MP:3000003 | abnormal Ebner's gland morphology | any structural anomaly of the serous salivary glands which reside adjacent to the moats surrounding the circumvallate and foliate papillae just anterior to the posterior third of the tongue, anterior to the terminal sulcus; these exocrine glands secrete l |
HP:0000963 | Thin skin | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0001263 | Global developmental delay | MP:3000003 | abnormal Ebner's gland morphology | any structural anomaly of the serous salivary glands which reside adjacent to the moats surrounding the circumvallate and foliate papillae just anterior to the posterior third of the tongue, anterior to the terminal sulcus; these exocrine glands secrete l |
HP:0011302 | Long palm | MP:0013600 | testis degeneration | a retrogressive impairment of function or destruction of either or both of the male reproductive glands |
HP:0001582 | Redundant skin | MP:0020321 | increased vascular endothelial cell apoptosis | increase in the timing or the number of vascular endothelial cells undergoing programmed cell death |
HP:0004942 | Aortic aneurysm | MP:0020321 | increased vascular endothelial cell apoptosis | increase in the timing or the number of vascular endothelial cells undergoing programmed cell death |
HP:0001249 | Intellectual disability | MP:0020316 | decreased vascular endothelial cell proliferation | decrease in the expansion rate of any vascular endothelial cell population by cell division |
HP:0002812 | Coxa vara | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0000563 | Keratoconus | MP:0013743 | ciliary body hypoplasia | underdevelopment or reduced size, usually due to a reduced number of cells, of the thickened portion of the vascular tunic which lies between the choroid and the iris |
HP:0005344 | Abnormality of the carotid arteries | MP:0014178 | increased brain apoptosis | increase in the number of cells of the brain undergoing programmed cell death |
HP:0000400 | Macrotia | MP:0020309 | increased creatine kinase activity | increased ability of to catalyze the reaction: ATP + creatine = N-phosphocreatine + ADP + 2 H(+). |
HP:0002020 | Gastroesophageal reflux | MP:0014178 | increased brain apoptosis | increase in the number of cells of the brain undergoing programmed cell death |
HP:0001166 | Arachnodactyly | MP:0020321 | increased vascular endothelial cell apoptosis | increase in the timing or the number of vascular endothelial cells undergoing programmed cell death |
HP:0001635 | Congestive heart failure | MP:0020329 | decreased capillary density | reduction in the number of capillaries in a given cross-sectional area of a tissue |
HP:0001658 | Myocardial infarction | MP:0020137 | decreased bone mineralization | decrease in the rate at which minerals are deposited into bone |
HP:0000545 | Myopia | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0000272 | Malar flattening | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0004209 | Clinodactyly of the 5th finger | MP:0020157 | abnormal behavioral response to alcohol | any anomaly in the behavioral response induced by alcohol, such as induced hyperactivity or stereotypic behavior |
HP:0001838 | Rocker bottom foot | MP:0020137 | decreased bone mineralization | decrease in the rate at which minerals are deposited into bone |
HP:0012745 | Short palpebral fissure | MP:0020137 | decreased bone mineralization | decrease in the rate at which minerals are deposited into bone |
HP:0007495 | Prematurely aged appearance | MP:0020321 | increased vascular endothelial cell apoptosis | increase in the timing or the number of vascular endothelial cells undergoing programmed cell death |
HP:0000023 | Inguinal hernia | MP:0020321 | increased vascular endothelial cell apoptosis | increase in the timing or the number of vascular endothelial cells undergoing programmed cell death |
HP:0000256 | Macrocephaly | MP:0020309 | increased creatine kinase activity | increased ability of to catalyze the reaction: ATP + creatine = N-phosphocreatine + ADP + 2 H(+). |
HP:0100585 | Telangiectasia of the skin | MP:0014127 | increased thymoma incidence | greater than the expected number of a malignant neoplasm originating from the epithelial cells of the thymus, occurring in a specific population in a given time period; thymoma is an uncommon tumor linked with myasthenia gravis and other autoimmune diseas |
HP:0005692 | Joint hyperflexibility | MP:0012125 | decreased bronchoconstrictive response | reduction in the expected bronchoconstrictive response to provocation challenge with lipopolysaccharide, bradykinin, histamine or other antigen/allergen or agent, often measured by plethysmography |
HP:0002647 | Aortic dissection | MP:0012125 | decreased bronchoconstrictive response | reduction in the expected bronchoconstrictive response to provocation challenge with lipopolysaccharide, bradykinin, histamine or other antigen/allergen or agent, often measured by plethysmography |
HP:0001119 | Keratoglobus | MP:0011642 | abnormal bone collagen fibril morphology | any structural anomaly of the connective tissue bundles in the extracellular matrix of bone tissue that are composed of collagen, and play a role in tissue strength and elasticity |
HP:0100633 | Esophagitis | MP:0013602 | abnormal Leydig cell differentiation | atypical formation of or inability to produce the interstitial cells that are found adjacent to the seminiferous tubules in the testicle and produce testosterone in the presence of luteinizing hormone; in most mammals, normal Leydig cell (LC) development |
HP:0000974 | Hyperextensible skin | MP:0020254 | decreased collagen level | decreased level of the main structural protein of the various connective tissues in animals |
HP:0000822 | Hypertension | MP:0020216 | decreased circulating complement protein level | less than normal levels of the serum proteins that act sequentially to allow for the direct killing of microbes, the disposal of immune complexes, and the regulation of other immune processes |
HP:0006543 | Cardiorespiratory arrest | MP:0011100 | preweaning lethality, complete penetrance | death of all organisms of a given genotype in a population between fertilization and weaning age (Mus: approximately 3-4 weeks of age) |
Disease ID | 734 |
---|---|
Disease | arterial tortuosity syndrome |
Case | (Waiting for update.) |